Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a breakdown of […]
InMed Pharmaceuticals Inc. , a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced that an abstract.
InMed Pharmaceuticals: InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Equities research analysts expect that InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating) will announce ($0.23) earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have made estimates for InMed Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.25) and the highest estimate coming in at ($0.21). InMed Pharmaceuticals posted […]
Equities analysts expect InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating) to announce ($0.23) earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have made estimates for InMed Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.21). InMed Pharmaceuticals posted earnings per share of ($0.41) in the same […]